1 / 9An increasing array of scientists, biotechnology companies, billionaires, and research institutions are pouring resources into longevity studies. Although current treatments cannot halt aging or significantly prolong the human lifespan, experts are optimistic that future medical breakthroughs could lead to improvements in health and moderation of biological aging. (Image: Canva)
2 / 9Altos Labs specializes in cellular rejuvenation research. Based in the US, it is a prominent player in the longevity field, focusing on cell regeneration and healthy aging studies, supported by influential investors like Jeff Bezos and tech mogul Yuri Milner. (Image: Reuters)
3 / 9Calico, founded by Alphabet (Google’s parent company), focuses on aging and age-related diseases research. Collaborating with scientists and institutes, the company engages in long-term healthcare and biological studies, with Larry Page closely involved in the venture. (Image: Reuters)
4 / 9Retro Biosciences aims to promote a longer healthy lifespan. This US-based firm is backed by Sam Altman, who has expressed notable interest in longevity and biotechnology advancements. (Image: Reuters)
5 / 9Numerous smaller biotech firms are also delving into aging research. Unity Biotechnology targets therapies aimed at aging cells, while BioAge Labs applies artificial intelligence and biomarkers to investigate aging pathways. Insilico Medicine is leveraging AI for drug discovery related to aging therapies, and Life Biosciences explores cellular mechanisms tied to aging. (Image: Canva)
6 / 9Bryan Johnson has sparked global interest with his anti-aging initiative known as ‘Blueprint.’ This program monitors aspects like diet, sleep, exercise, and medical evaluations, aiming to enhance long-term health and mitigate biological aging. (Image: Wikimedia Commons)
7 / 9Investor Peter Thiel remains a significant supporter of longevity and anti-aging research, making investments in various biotechnology and healthcare enterprises. His financial backing has helped elevate the profile of this sector globally. (Image: Reuters)
8 / 9Countries including the US and China are ramping up research into aging. The US has established itself as a major hub for biotech firms, while Japan is investing significantly in aging studies due to its aging population. China is also boosting its investments in biotechnology and healthcare advancements. (Image: Canva)
9 / 9Saudi Arabia, Switzerland, and the UK are boosting their investments in biotech. Saudi Arabia is funneling funds into biotech ventures, Switzerland is recognized for its pharmaceutical research, and the UK is fostering longevity science through academic institutions and startup initiatives. (Image: Canva)
